Rosa Maria Silva Garcia Grenha

Title: Rosa Maria Silva Garcia Grenha: Innovator in Biomedical Research

Introduction

Rosa Maria Silva Garcia Grenha is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of biomedical research, particularly in the development of innovative therapeutic solutions. With a total of three patents to her name, her work focuses on addressing critical health issues related to albumin levels in the body.

Latest Patents

One of her latest patents involves FC receptor (FcRn) binding peptides and their uses. This invention includes isolated polypeptides that specifically block the interaction between the neonatal Fc receptor (FcRn) and albumin. By blocking this interaction, the invention aims to treat diseases and conditions caused by increased amounts of albumin or modified albumin that possess pathogenic properties. The methods provided also include using these isolated polypeptides to treat various diseases associated with elevated albumin levels. Additionally, the invention encompasses isolated polypeptides capable of binding to a non-IgG and non-albumin competitive site on an FcRn alpha 3 domain. These polypeptides can be useful for tracking FcRn without inhibiting IgG or albumin binding or function.

Career Highlights

Throughout her career, Rosa has worked with esteemed organizations such as Brigham and Women's Hospital, Inc. and Biogen MA Inc. Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Rosa has collaborated with notable professionals in her field, including Richard S. Blumberg and Timo Rath. These collaborations have further enriched her research and innovation efforts.

Conclusion

Rosa Maria Silva Garcia Grenha is a trailblazer in biomedical research, with her innovative patents addressing critical health challenges. Her contributions continue to impact the field positively, showcasing her dedication to improving patient outcomes.